Core Viewpoint - The tax system of Hainan Free Trade Port has been initially established, with companies expected to benefit the most from tax policies after the port's closure [1][3]. Tax Policy Overview - The tax system is characterized by "zero tariffs" and "low tax rates," aiming to align with high-level international trade rules [3][4]. - The range of "zero tariff" products has expanded from 1,900 to approximately 6,600 items, increasing the coverage from 21% to 74% of product categories [3][4]. - The "low tax rate" policy continues to encourage specific industries with a reduced corporate income tax rate of 15% and exemptions for high-end talent [4][5]. Benefits for Enterprises - Companies importing equipment can save about 20% in costs due to the elimination of import tariffs (5%-10%) and value-added tax (13%) [4][5]. - Enterprises engaged in processing and selling imported raw materials can benefit from both "zero tariff" and additional tax exemptions [5]. - The corporate income tax reduction applies to over 1,100 industry categories, including biomedicine and green building materials [5][6]. Economic Impact - The series of tax policies create a virtuous cycle of "policy guidance - investment aggregation - industrial upgrading - talent inflow" [6].

Group 1 - The stock price of Meihao Medical as of August 22, 2025, closed at 23.25 yuan, down by 0.15 yuan, representing a decline of 0.64% from the previous trading day [1] - The trading volume on that day was 346,668 hands, with a total transaction value of 797 million yuan [1] - Meihao Medical specializes in the research, production, and sales of medical devices, including medical catheters and medical dressings, and is headquartered in Guangdong Province [1] Group 2 - On May 23, 2025, Meihao Medical's board of directors approved a proposal for the initial grant of restricted stock to incentive targets, completing the grant process [1] - On August 22, 2025, the net outflow of main funds for Meihao Medical was 71.7033 million yuan, accounting for 1.97% of the circulating market value [1] - Over the past five trading days, the cumulative net outflow was 27.7974 million yuan, representing 0.77% of the circulating market value [1]

Group 1 - The latest stock price of the company is 14.83 yuan, with an increase of 0.01 yuan compared to the previous trading day. The intraday high reached 14.94 yuan, and the low dipped to 14.68 yuan, with a total trading volume of 1.07 billion yuan [1] - The company operates in the medical device industry, focusing on the research, production, and sales of medical catheters and other medical devices. Its product range includes anesthesia, urology, respiratory, and hemodialysis fields [1] - The latest announcement indicates that non-independent director Chen Yungui has resigned from the board due to work adjustments but will retain the position of deputy general manager. Additionally, Shu Jie has been elected as the employee director of the company's fifth board of directors [1] Group 2 - On the day of the report, the main capital flow showed a net outflow of 4.0961 million yuan, with a cumulative net outflow of 10.5962 million yuan over the past five trading days [1]